Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1)

• Hideto Kameda,
• Kohei Hagimori,
• Yoji Morisaki,
• Thorsten Holzkämper,
• Ayako Konomi,
• Hiroaki Dobashi

Affiliations

Hideto Kameda

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University

Kohei Hagimori

Eli Lilly Japan K.K.

Yoji Morisaki

Eli Lilly Japan K.K.

Thorsten Holzkämper

Eli Lilly and Company

Ayako Konomi

Eli Lilly Japan K.K.

Hiroaki Dobashi

Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University